Abstract
The rationale for surfactant replacement therapy in patients with acute respiratory distress syndrome (ARDS) is to restore the normal composition of the surfactant system, as well as to overcome ongoing inactivation of present surfactant. Indeed, surfactant replacement therapy can normalize the composition of the surfactant system and restore its surface activity, which results in restoration of the gas exchange. Several phase II- and phase III-studies have been performed to investigate safety and efficacy of surfactant replacement therapy in patients with ARDS. In this manuscript we will discuss the differences in the composition of exogenous surfactant, the diverse modes of delivery of surfactant, and timing of therapy, in relation to the efficacy of surfactant instillation in several published and yet unpublished studies.
Keywords: Additive Drug, ARDS-Patients, exogenous surfactant
Current Drug Targets
Title: Is Surfactant a Promising Additive Drug in ALI / ARDS-Patients?
Volume: 5 Issue: 5
Author(s): Marcus J. Schultz and Jozef Kesecioglu
Affiliation:
Keywords: Additive Drug, ARDS-Patients, exogenous surfactant
Abstract: The rationale for surfactant replacement therapy in patients with acute respiratory distress syndrome (ARDS) is to restore the normal composition of the surfactant system, as well as to overcome ongoing inactivation of present surfactant. Indeed, surfactant replacement therapy can normalize the composition of the surfactant system and restore its surface activity, which results in restoration of the gas exchange. Several phase II- and phase III-studies have been performed to investigate safety and efficacy of surfactant replacement therapy in patients with ARDS. In this manuscript we will discuss the differences in the composition of exogenous surfactant, the diverse modes of delivery of surfactant, and timing of therapy, in relation to the efficacy of surfactant instillation in several published and yet unpublished studies.
Export Options
About this article
Cite this article as:
Schultz J. Marcus and Kesecioglu Jozef, Is Surfactant a Promising Additive Drug in ALI / ARDS-Patients?, Current Drug Targets 2004; 5 (5) . https://dx.doi.org/10.2174/1389450043345399
DOI https://dx.doi.org/10.2174/1389450043345399 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issue: Enzymatic Studies in Medicinal Chemistry of Neglected Diseases)
Current Protein & Peptide Science Theoretical Analysis of the Binding of Potential Inhibitors to Protein Kinases MK2 and MK3
Medicinal Chemistry Whole-Body Autoradiography In Drug Discovery
Current Drug Metabolism Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists
Current Medicinal Chemistry Peptide Mediated siRNA Delivery
Current Topics in Medicinal Chemistry Glycine Transporter-1 Inhibitors as Novel Therapeutic Drugs for Schizophrenia
Central Nervous System Agents in Medicinal Chemistry Biosensors - A Miraculous Detecting Tool in Combating the War against COVID-19
Current Pharmaceutical Biotechnology N-type Calcium Channel Blockers: Novel Therapeutics for the Treatment of Pain
Medicinal Chemistry Insect Peptides – Perspectives in Human Diseases Treatment
Current Medicinal Chemistry Measuring the Infectiousness of Persons with HIV-1: Opportunities for Preventing Sexual HIV-1 Transmission
Current HIV Research Design, Synthesis and Biological Evaluation of Benzopyran Derivatives as KATP Channel Openers
Letters in Drug Design & Discovery Quinic and Digallic acids from <i>Pistacia atlantica</i> Desf. Leaves Extracts as Potent Dual Effect Inhibitors against main Protease and RNA-dependent RNA Polymerase of SARS-CoV-2
Current Computer-Aided Drug Design Use of Remote Sensing Techniques for Robust Digital Change Detection of Land: A Review
Recent Patents on Space Technology The Effect of Aspirin on the Prevention of Pro-thrombotic States in Hospitalized COVID-19 Patients: Systematic Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Neurotrophic Factor Treatment After Spinal Root Avulsion Injury
Central Nervous System Agents in Medicinal Chemistry Can Enzyme Engineering Benefit from the Modulation of Protein Motions? Lessons Learned from NMR Relaxation Dispersion Experiments
Protein & Peptide Letters Pharmacophoric Models and 3D QSAR Studies of the Adenosine Receptor Ligands
Current Topics in Medicinal Chemistry Implications of Dynamic Occupancy, Binding Kinetics, and Channel Gating Kinetics for hERG Blocker Safety Assessment and Mitigation
Current Topics in Medicinal Chemistry Mediterranean Diet Adherence and Physical Activity Level in Adolescents During the Lockdown in the COVID-19 Pandemic: A Cross-sectional Study in Greek Island of Rhodes
Current Nutrition & Food Science Two-Dimensional (2D) In Silico Models for Absorption, Distribution, Metabolism, Excretion and Toxicity (ADME/T) in Drug Discovery
Current Topics in Medicinal Chemistry